Alps Advisors Inc Pliant Therapeutics, Inc. Transaction History
Alps Advisors Inc
- $14.1 Billion
- Q1 2024
A detailed history of Alps Advisors Inc transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 42,485 shares of PLRX stock, worth $449,491. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,485
Previous 41,062
3.47%
Holding current value
$449,491
Previous $743,000
14.8%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding PLRX
# of Institutions
148Shares Held
63.8MCall Options Held
417KPut Options Held
123K-
Deep Track Capital, LP Greenwich, CT5.75MShares$60.8 Million2.83% of portfolio
-
Black Rock Inc. New York, NY4.66MShares$49.3 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.96MShares$41.9 Million0.01% of portfolio
-
First Light Asset Management, LLC Edina, MN3.53MShares$37.4 Million4.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$36.8 Million0.0% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $515M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...